601 related articles for article (PubMed ID: 9811831)
21. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
[TBL] [Abstract][Full Text] [Related]
22. Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome.
Carethers JM; Furnari FB; Zigman AF; Lavine JE; Jones MC; Graham GE; Teebi AS; Huang HJ; Ha HT; Chauhan DP; Chang CL; Cavenee WK; Boland CR
Cancer Res; 1998 Jul; 58(13):2724-6. PubMed ID: 9661881
[TBL] [Abstract][Full Text] [Related]
23. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
[TBL] [Abstract][Full Text] [Related]
24. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
25. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
26. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
27. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
28. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
29. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
30. Germline mutations of the PTEN/MMAC1 gene in Japanese patients with Cowden disease.
Kohno T; Takahashi M; Fukutomi T; Ushio K; Yokota J
Jpn J Cancer Res; 1998 May; 89(5):471-4. PubMed ID: 9685848
[TBL] [Abstract][Full Text] [Related]
31. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
Weng LP; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
[TBL] [Abstract][Full Text] [Related]
33. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
[TBL] [Abstract][Full Text] [Related]
35. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease.
Chi SG; Kim HJ; Park BJ; Min HJ; Park JH; Kim YW; Dong SH; Kim BH; Lee JI; Chang YW; Chang R; Kim WK; Yang MH
Gastroenterology; 1998 Nov; 115(5):1084-9. PubMed ID: 9797362
[TBL] [Abstract][Full Text] [Related]
36. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
Tolkacheva T; Chan AM
Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513
[TBL] [Abstract][Full Text] [Related]
38. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
[TBL] [Abstract][Full Text] [Related]
39. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
40. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
Li DM; Sun H
Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
